These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3977753)

  • 1. Mitomycin and fluorouracil with concomitant radiotherapy in head and neck cancer.
    Kaplan MJ; Hahn SS; Johns ME; Stewart FM; Constable WC; Cantrell RW
    Arch Otolaryngol; 1985 Apr; 111(4):220-2. PubMed ID: 3977753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck.
    Macmillan CH; Carrick K; Bradley PJ; Morgan DA
    Br J Radiol; 1991 Oct; 64(766):941-6. PubMed ID: 1954537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin and fluorouracil in combination with concomitant radiotherapy: a potentially curable approach for locally advanced head and neck squamous cell carcinoma.
    Rastogi M; Srivastava M; Chufal KS; Pant MC; Srivastava K; Bhatt MB
    Jpn J Clin Oncol; 2005 Oct; 35(10):572-9. PubMed ID: 16186175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified radical neck dissection and minimal invasive tumor surgery in the middle of split course of concomitant chemoradiotherapy of advanced HNSCC.
    Schwentner I; Schmutzhard J; Andrle J; Haidenberger A; Thumfart WF; De Vries A; Sprinzl GM
    Auris Nasus Larynx; 2007 Mar; 34(1):85-9. PubMed ID: 17074457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer.
    Weissberg JB; Son YH; Papac RJ; Sasaki C; Fischer DB; Lawrence R; Rockwell S; Sartorelli AC; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):3-9. PubMed ID: 2501243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
    Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study.
    Thomas G; Dembo A; Beale F; Bean H; Bush R; Herman J; Pringle J; Rawlings G; Sturgeon J; Fine S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1785-90. PubMed ID: 6434500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.
    Haffty BG; Son YH; Papac R; Sasaki CT; Weissberg JB; Fischer D; Rockwell S; Sartorelli AC; Fischer JJ
    J Clin Oncol; 1997 Jan; 15(1):268-76. PubMed ID: 8996152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
    Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
    J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
    Vokes EE; Stenson K; Rosen FR; Kies MS; Rademaker AW; Witt ME; Brockstein BE; List MA; Fung BB; Portugal L; Mittal BB; Pelzer H; Weichselbaum RR; Haraf DJ
    J Clin Oncol; 2003 Jan; 21(2):320-6. PubMed ID: 12525525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
    Keil F; Selzer E; Berghold A; Reinisch S; Kapp KS; De Vries A; Greil R; Bachtiary B; Tinchon C; Anderhuber W; Burian M; Kasparek AK; Elsäßer W; Kainz H; Riedl R; Kopp M; Kornek G
    Eur J Cancer; 2013 Jan; 49(2):352-9. PubMed ID: 22981499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.
    Taylor SG; Murthy AK; Vannetzel JM; Colin P; Dray M; Caldarelli DD; Shott S; Vokes E; Showel JL; Hutchinson JC
    J Clin Oncol; 1994 Feb; 12(2):385-95. PubMed ID: 8113846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
    Vokes EE; Panje WR; Schilsky RL; Mick R; Awan AM; Moran WJ; Goldman MD; Tybor AG; Weichselbaum RR
    J Clin Oncol; 1989 Jun; 7(6):761-8. PubMed ID: 2715806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer.
    Olver IN; Hughes PG; Smith JG; Narayan K; Bishop JF
    Eur J Cancer; 1996 Feb; 32A(2):249-54. PubMed ID: 8664036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.
    Merlano M; Rosso R; Sertoli MR; Bonelli L; Margarino G; Grimaldi A; Benasso M; Gardin G; Corvó R; Scarpati D
    J Clin Oncol; 1988 Apr; 6(4):627-32. PubMed ID: 2451713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.